45 results on '"Bertolazzi G"'
Search Results
2. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
- Author
-
Pipitone, R.M., primary, Malvestiti, F., additional, Pennisi, G., additional, Jamialahmadi, O., additional, Dongiovanni, P., additional, Bertolazzi, G., additional, Pihlajamäki, J., additional, Yki-Järvinen, H., additional, Vespasiani-Gentilucci, U., additional, Tavaglione, F., additional, Maurotti, S., additional, Bianco, C., additional, Di Maria, G., additional, Enea, M., additional, Fracanzani, A.L., additional, Kärjä, V., additional, Lupo, G., additional, Männistö, V., additional, Meroni, M., additional, Piciotti, R., additional, Qadri, S., additional, Zito, R., additional, Craxì, A., additional, Di Marco, V., additional, Cammà, C., additional, Tripodo, C., additional, Valenti, L., additional, Romeo, S., additional, Petta, S., additional, and Grimaudo, S., additional
- Published
- 2023
- Full Text
- View/download PDF
3. OC.08.1 PROGRAMMED CELL DEATH 1 GENETIC VARIANT AND LIVER DAMAGE IN NONALCOHOLIC FATTY LIVER DISEASE
- Author
-
Pipitone, R.M., primary, Malvestiti, F., additional, Pennisi, G., additional, Jamialahmadi, O., additional, Dongiovanni, P., additional, Bertolazzi, G., additional, Pihlajamaki, J., additional, Yki-Jarvinen, H., additional, Vespasiani-Gentilucci, U., additional, Tavaglione, F., additional, Maurotti, S., additional, Bianco, C., additional, Di Maria, G., additional, Enea, M., additional, Fracanzani, A., additional, Karja, V., additional, Lupo, G., additional, Mannisto, V., additional, Meroni, M., additional, Piciotti, R., additional, Qadri, S., additional, Zito, R., additional, Craxi, A., additional, Di Marco, V., additional, Camma, C., additional, Tripodo, C., additional, Valenti, L., additional, Romeo, S., additional, Petta, S., additional, and Grimaudo, S., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Identification of an effective chemotherapy and DNA damage response inhibitor combination for diffuse large b cell lymphoma
- Author
-
Chan, A., primary, Anbuselvan, A., additional, Upadhyayula, S.S., additional, Jemimah, S., additional, Jaynes, P., additional, Hoppe, M.M., additional, Wardyn, J.D., additional, Goh, J., additional, Bertolazzi, G., additional, Foiani, M., additional, O’Connor, M.J., additional, Chow, E.K., additional, Tripodo, C., additional, and Jeyasekharan, A.D., additional
- Published
- 2022
- Full Text
- View/download PDF
5. Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas
- Author
-
L'Imperio, V, Morello, G, Vegliante, M, Cancila, V, Bertolazzi, G, Mazzara, S, Belmonte, B, Mangogna, A, Balzarini, P, Corral, L, Lopez, G, Di Napoli, A, Facchetti, F, Pagni, F, Tripodo, C, L'Imperio, Vincenzo, Morello, Gaia, Vegliante, Maria Carmela, Cancila, Valeria, Bertolazzi, Giorgio, Mazzara, Saveria, Belmonte, Beatrice, Mangogna, Alessandro, Balzarini, Piera, Corral, Lilia, Lopez, Gianluca, Di Napoli, Arianna, Facchetti, Fabio, Pagni, Fabio, Tripodo, Claudio, L'Imperio, V, Morello, G, Vegliante, M, Cancila, V, Bertolazzi, G, Mazzara, S, Belmonte, B, Mangogna, A, Balzarini, P, Corral, L, Lopez, G, Di Napoli, A, Facchetti, F, Pagni, F, Tripodo, C, L'Imperio, Vincenzo, Morello, Gaia, Vegliante, Maria Carmela, Cancila, Valeria, Bertolazzi, Giorgio, Mazzara, Saveria, Belmonte, Beatrice, Mangogna, Alessandro, Balzarini, Piera, Corral, Lilia, Lopez, Gianluca, Di Napoli, Arianna, Facchetti, Fabio, Pagni, Fabio, and Tripodo, Claudio
- Abstract
The GC reaction results in the selection of B cells acquiring effector Ig secreting ability by progressing toward plasmablastic differentiation. This transition is associated with exclusion from the GC microenvironment. The aberrant expansion of plasmablastic elements within the GC fringes configures an atypical condition, the biological characteristics of which have not been defined yet. We investigated the in situ immunophenotypical and transcriptional characteristics of a nonclonal germinotropic expansion of plasmablastic elements (GEx) occurring in the tonsil of a young patient. Compared to neighboring GC and perifollicular regions, the GEx showed a distinctive signature featuring key regulators of plasmacytic differentiation, cytokine signaling, and cell metabolism. The GEx signature was tested in the setting of diffuse large B-cell lymphoma (DLBCL) as a prototypical model of lymphomagenesis encompassing transformation at different stages of GC and post-GC functional differentiation. The signature outlined DLBCL clusters with different immune microenvironment composition and enrichment in genetic subtypes. This report represents the first insight into the transcriptional features of a germinotropic plasmablastic burst, shedding light into the molecular hallmarks of B cells undergoing plasmablastic differentiation and aberrant expansion within the noncanonical setting of the GC microenvironment.
- Published
- 2022
6. Analisi e monitoraggio della diffusione del Covid19 in Italia: il gruppo CoViSTAT19
- Author
-
Muggeo V, Consiglio A, Sottile G, Genova V, Bertolazzi G, Porcu M, Muggeo V, Consiglio A, Sottile G, Genova V, Bertolazzi G, and Porcu M
- Subjects
covid-19 ,regressione segmented ,tasso di crescita ,monitoraggio - Abstract
In questo contributo vogliamo discutere di un modello di regressione segmented per valutare e quantificare l’effetto delle misure di contenimento individuando gli istanti temporali in cui la diffusione della malattia rallenta.
- Published
- 2020
7. DIGITAL SPATIAL PROFILING OF DIFFUSE LARGE B‐CELL LYMPHOMAS REVEALS STING AS AN IMMUNE‐RELATED DETERMINANT OF SURVIVAL AFTER R‐CHOP THERAPY
- Author
-
Hoppe, M. M, primary, Fan, S, additional, Jaynes, P, additional, Peng, Y, additional, Liu, X, additional, De Mel, S, additional, Poon, L, additional, Chan, E, additional, Lee, J, additional, Chee, Y. L, additional, Ong, C. K, additional, Tang, T, additional, Lim, S. T, additional, Chng, W. J, additional, Grigoropoulos, N. F, additional, VanSchoiack, A, additional, Bertolazzi, G, additional, Ng, Siok‐B, additional, Tripodo, C, additional, and Jeyasekharan, A. D, additional
- Published
- 2021
- Full Text
- View/download PDF
8. Gender and 5-years course of psychosis patients: focus on clinical and social variables
- Author
-
Comacchio, C, Lasalvia, A, Bonetto, C, Cristofalo, D, Miglietta, E, Petterlini, S, De Santi, K, Tosato, S, Riolo, R, Cremonese, C, Ceccato, E, Zanatta, G, Ruggeri, M, Tansella, M, Bertani, M, Brambilla, P, Marrella, G, Bissoli, S, Perlini, C, Tito, P, Lunardon, M, Gava, F, Borso, E, Grandina, L, Paliotto, M, Roggia, L, Danieli, A, Poloni, C, Altiero, Mr, Piazza, F, Busana, C, Campi, A, Zanconato, A, Zamorani, P, Binotto, R, Caneva, A, Lazzarin, E, Zordan, G, Dolce, C, Fanchin, Gb, Negro, C, Gardellin, F, Crestale, M, Paiola, L, Sale, A, Morandin, I, Biondi, E, Favaretto, Acg, Geatti, S, Urbani, P, De Rossi, M, Spessotto, J, Penelope, R, Grando, L, Sgnaolin, M, Tozzini, C, Visentin, G, Schiavon, L, Gentile, B, Bolacchi, Mg, Marzotto, L, Moni, F, Rossi, L, Amalric, I, Miceli, C, De Zordo, Mr, Ramon, L, Russo, S, Rossi, R, Casagrande, G, De Nardo, V, Facchetti, A, Ramaciotti, F, Marangon, V, Coppola, G, Marcolin, A, Meneghini, P, Sbraccia, F, Segato, C, Cappellari, L, Cutugno, M, Meneghetti, L, Longhin, L, Paoleschi, B, Scalabrin, D, Antonello, L, Purgato, A, Santucci, G, Tosin, C, Volpato, R, Zurlo, R, Zucchetto, M, Pedron, M, Pinton, S, Benetazzo, M, Pavan, L, Semenzin, M, Sifari, L, Zorzi, F, Martucci, Mm, Magno, N, Meloni, G, Toniolo, E, Pavanati, M, Destro, E, Finotti, L, Fiorio, R, Marsilio, A, Pedrocco, N, Pollola, P, Lazzarotto, L, Nose, F, Rossin, P, Vivenza, V, Mazzoncini, R, Urbani, Andrea, Bianchi, L, Carcereri, G, Lunardi, L, Migliorini, G, Perdona, G, Piazza, C, Lamonaca, D, D'Agostini, G, Boggian, I, Piccione, G, Saladini, E, Gomez, F, Frazzingaro, S, Nicolaou, S, Cordioli, L, Bertolazzi, G, Pagliuca, V, Abate, M, Bortolomasi, M, Giacopuzzi, M, Segala, M, De Nardi, F, Basetto, F, Bernardis, C, Bezzetto, A, and Santi, M
- Subjects
Adult ,Male ,Mental Health Services ,First episode psychosis ,Psychosis ,medicine.medical_specialty ,Time Factors ,Adolescent ,FEP ,Gender ,Insight ,Needs ,Psychopathology ,Unmet needs ,Cohort Studies ,Young Adult ,03 medical and health sciences ,Settore BIO/12 - BIOCHIMICA CLINICA E BIOLOGIA MOLECOLARE CLINICA ,Sex Factors ,0302 clinical medicine ,Female patient ,medicine ,Humans ,Psychiatry ,Depressive symptoms ,Demography ,Psychiatric Status Rating Scales ,Health Services Needs and Demand ,business.industry ,Obstetrics and Gynecology ,Middle Aged ,medicine.disease ,030227 psychiatry ,Psychiatry and Mental health ,Insight into illness ,Italy ,Psychotic Disorders ,Male patient ,Female ,business ,Social Adjustment ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
Most studies on gender and psychosis have focused on gender differences at illness onset or on the long-term outcome, whereas little is known about the impact of gender on the first years after psychosis onset. A total of 185 first episode psychosis (FEP) patients were followed for 5 years after psychosis onset, and gender differences were explored in psychopathology (PANSS), needs for care (CAN), and insight (SAI-E). Male patients showed more negative symptoms than females over time, whereas female patients showed higher levels of depressive symptoms than males throughout the study period. In addition, female patients presented more functioning unmet needs for care, but higher levels of insight into illness than males. Therapy and rehabilitative programs for FEP patients should be gender-targeted, as gender has proved to impact on psychopathology, needs for care, and insight in the very first years following psychosis onset.
- Published
- 2019
- Full Text
- View/download PDF
9. Gender and 5-years course of psychosis patients: focus on clinical and social variables
- Author
-
Comacchio, C, Lasalvia, A, Bonetto, C, Cristofalo, D, Miglietta, E, Petterlini, S, De Santi, K, Tosato, S, Riolo, R, Cremonese, C, Ceccato, E, Zanatta, G, Ruggeri, M, Tansella, M, Bertani, M, Brambilla, P, Marrella, G, Bissoli, S, Perlini, C, Tito, P, Lunardon, M, Gava, F, Borso, E, Grandina, L, Paliotto, M, Roggia, L, Danieli, A, Poloni, C, Altiero, Mr, Piazza, F, Busana, C, Campi, A, Zanconato, A, Zamorani, P, Binotto, R, Caneva, A, Lazzarin, E, Zordan, G, Dolce, C, Fanchin, Gb, Negro, C, Gardellin, F, Crestale, M, Paiola, L, Sale, A, Morandin, I, Biondi, E, Favaretto, Acg, Geatti, S, Urbani, P, De Rossi, M, Spessotto, J, Penelope, R, Grando, L, Sgnaolin, M, Tozzini, C, Visentin, G, Schiavon, L, Gentile, B, Bolacchi, Mg, Marzotto, L, Moni, F, Rossi, L, Amalric, I, Miceli, C, De Zordo, Mr, Ramon, L, Russo, S, Rossi, R, Casagrande, G, De Nardo, V, Facchetti, A, Ramaciotti, F, Marangon, V, Coppola, G, Marcolin, A, Meneghini, P, Sbraccia, F, Segato, C, Cappellari, L, Cutugno, M, Meneghetti, L, Longhin, L, Paoleschi, B, Scalabrin, D, Antonello, L, Purgato, A, Santucci, G, Tosin, C, Volpato, R, Zurlo, R, Zucchetto, M, Pedron, M, Pinton, S, Benetazzo, M, Pavan, L, Semenzin, M, Sifari, L, Zorzi, F, Martucci, Mm, Magno, N, Meloni, G, Toniolo, E, Pavanati, M, Destro, E, Finotti, L, Fiorio, R, Marsilio, A, Pedrocco, N, Pollola, P, Lazzarotto, L, Nose, F, Rossin, P, Vivenza, V, Mazzoncini, R, Urbani, Andrea, Bianchi, L, Carcereri, G, Lunardi, L, Migliorini, G, Perdona, G, Piazza, C, Lamonaca, D, D'Agostini, G, Boggian, I, Piccione, G, Saladini, E, Gomez, F, Frazzingaro, S, Nicolaou, S, Cordioli, L, Bertolazzi, G, Pagliuca, V, Abate, M, Bortolomasi, M, Giacopuzzi, M, Segala, M, De Nardi, F, Basetto, F, Bernardis, C, Bezzetto, A, Santi, M, Urbani, A (ORCID:0000-0001-9168-3174), Comacchio, C, Lasalvia, A, Bonetto, C, Cristofalo, D, Miglietta, E, Petterlini, S, De Santi, K, Tosato, S, Riolo, R, Cremonese, C, Ceccato, E, Zanatta, G, Ruggeri, M, Tansella, M, Bertani, M, Brambilla, P, Marrella, G, Bissoli, S, Perlini, C, Tito, P, Lunardon, M, Gava, F, Borso, E, Grandina, L, Paliotto, M, Roggia, L, Danieli, A, Poloni, C, Altiero, Mr, Piazza, F, Busana, C, Campi, A, Zanconato, A, Zamorani, P, Binotto, R, Caneva, A, Lazzarin, E, Zordan, G, Dolce, C, Fanchin, Gb, Negro, C, Gardellin, F, Crestale, M, Paiola, L, Sale, A, Morandin, I, Biondi, E, Favaretto, Acg, Geatti, S, Urbani, P, De Rossi, M, Spessotto, J, Penelope, R, Grando, L, Sgnaolin, M, Tozzini, C, Visentin, G, Schiavon, L, Gentile, B, Bolacchi, Mg, Marzotto, L, Moni, F, Rossi, L, Amalric, I, Miceli, C, De Zordo, Mr, Ramon, L, Russo, S, Rossi, R, Casagrande, G, De Nardo, V, Facchetti, A, Ramaciotti, F, Marangon, V, Coppola, G, Marcolin, A, Meneghini, P, Sbraccia, F, Segato, C, Cappellari, L, Cutugno, M, Meneghetti, L, Longhin, L, Paoleschi, B, Scalabrin, D, Antonello, L, Purgato, A, Santucci, G, Tosin, C, Volpato, R, Zurlo, R, Zucchetto, M, Pedron, M, Pinton, S, Benetazzo, M, Pavan, L, Semenzin, M, Sifari, L, Zorzi, F, Martucci, Mm, Magno, N, Meloni, G, Toniolo, E, Pavanati, M, Destro, E, Finotti, L, Fiorio, R, Marsilio, A, Pedrocco, N, Pollola, P, Lazzarotto, L, Nose, F, Rossin, P, Vivenza, V, Mazzoncini, R, Urbani, Andrea, Bianchi, L, Carcereri, G, Lunardi, L, Migliorini, G, Perdona, G, Piazza, C, Lamonaca, D, D'Agostini, G, Boggian, I, Piccione, G, Saladini, E, Gomez, F, Frazzingaro, S, Nicolaou, S, Cordioli, L, Bertolazzi, G, Pagliuca, V, Abate, M, Bortolomasi, M, Giacopuzzi, M, Segala, M, De Nardi, F, Basetto, F, Bernardis, C, Bezzetto, A, Santi, M, and Urbani, A (ORCID:0000-0001-9168-3174)
- Abstract
Most studies on gender and psychosis have focused on gender differences at illness onset or on the long-term outcome, whereas little is known about the impact of gender on the first years after psychosis onset. A total of 185 first episode psychosis (FEP) patients were followed for 5 years after psychosis onset, and gender differences were explored in psychopathology (PANSS), needs for care (CAN), and insight (SAI-E). Male patients showed more negative symptoms than females over time, whereas female patients showed higher levels of depressive symptoms than males throughout the study period. In addition, female patients presented more functioning unmet needs for care, but higher levels of insight into illness than males. Therapy and rehabilitative programs for FEP patients should be gender-targeted, as gender has proved to impact on psychopathology, needs for care, and insight in the very first years following psychosis onset.
- Published
- 2020
10. 154 (PB034) - Identification of an effective chemotherapy and DNA damage response inhibitor combination for diffuse large b cell lymphoma
- Author
-
Chan, A., Anbuselvan, A., Upadhyayula, S.S., Jemimah, S., Jaynes, P., Hoppe, M.M., Wardyn, J.D., Goh, J., Bertolazzi, G., Foiani, M., O’Connor, M.J., Chow, E.K., Tripodo, C., and Jeyasekharan, A.D.
- Published
- 2022
- Full Text
- View/download PDF
11. Epidemiology of preeclampsia in a Sicilian Hospital
- Author
-
Pandolfo, MC, Catania, M, Dardanoni, G, Rinoldo, C, Bertolazzi, G, Ferrara, C, Palumbo, E, D'Anna, MR, Pandolfo, MC, Catania, M, Dardanoni, G, Rinoldo, C, Bertolazzi, G, Ferrara, C, Palumbo, E, and D'Anna, MR
- Subjects
Preeclampsia, epidemiology, Sicily, twin pregnancy - Abstract
Multivariate logistic regression has shown that the following variables are independent risk factors for preeclampsia: age, BMI, parity, and twin pregnancy. Moreover, preeclampsia is significantly associated with the examined clinical effects, confirming itself as a leading cause of maternal-fetal morbidity.
- Published
- 2016
12. Italy veers offshore to connect coastal cities
- Author
-
Bertolazzi, G.
- Subjects
Optical communications -- Italy ,Telecommunications industry - Published
- 1990
13. SPATIALLY‐RESOLVED TRANSCRIPTOMICS DEFINE CLINICALLY RELEVANT SUBSETS OF MACROPHAGES IN DIFFUSE LARGE B‐CELL LYMPHOMA.
- Author
-
Liu, M., Bertolazzi, G., Mulder, K., Sridhar, S., Tripodo, C., and Jeyasekharan, A. D.
- Subjects
DIFFUSE large B-cell lymphomas ,MACROPHAGES ,LYMPHOID tissue - Abstract
SPATIALLY-RESOLVED TRANSCRIPTOMICS DEFINE CLINICALLY RELEVANT SUBSETS OF MACROPHAGES IN DIFFUSE LARGE B-CELL LYMPHOMA B Introduction: b Tumor-associated macrophages (TAMs) are abundant immune cells in the microenvironment of diffuse large B-cell lymphoma (DLBCL) and are implicated in tumor progression and therapy resistance. Projection onto a macrophage single-cell RNA-sequencing atlas reveals the Non-relapse-DLBCL MacroSig to depict HES1/FOLR2-like macrophages, while relapse-DLBCL-MacroSig represents IL1B-like monocytes, with unique therapeutic vulnerabilities for each. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
14. Aripiprazole Versus Haloperidol in Combination With Clozapine for Treatment-Resistant Schizophrenia in Routine Clinical Care A Randomized, Controlled Trial
- Author
-
Barbui, C, Accordini, S, Nosè, M, Stroup, S, Purgato, M, Girlanda, F, Esposito, E, Veronese, A, Tansella, M, Cipriani, A, CHAT Clozapine Haloperidol Aripiprazole Trial, Study Group, Losavio, T, Percudani, M, Aldini, F, Appino, Mg, Artioli, P, Barale, F, Beneduce, R, Berardi, D, Bertolazzi, G, Biancosino, B, Bisogno, A, Bivi, R, Bogetto, F, Boso, M, Bozzani, A, Bucolo, P, Casale, M, Cascone, L, Ciammella, L, Cicolini, A, Cipresso, G, Colombo, P, Dal Santo, B, De Francesco, M, Di Lorenzo, G, Di Munzio, W, Erlicher, A, Ferrannini, L, Ferrato, F, Ferro, A, Fragomeno, N, Fricchione Parise, V, Frova, M, Gardellin, F, Garzotto, N, Giambartolomei, A, Giupponi, G, Grassi, L, Grazian, N, Grecu, L, Guerrini, G, Laddomada, F, Lazzarin, E, Lintas, C, Malchiodi, F, Malvini, L, Marchiaro, L, Marsilio, A, Mauri, Mc, Mautone, A, Menchetti, M, Migliorini, G, Mollica, M, Moretti, D, Mulè, S, Nicholau, S, Nosè, F, Occhionero, G, Pacilli, Am, Pecchioli, S, Petrosemolo, P, Piantato, E, Piazza, C, Pontarollo, F, Pycha, R, Quartesan, Roberto, Rillosi, L, Risso, F, Rizzo, R, Rocca, P, Roma, S, Rossattini, M, Rossi, G, Sala, A, Santilli, C, Saraò, G, Sarnicola, A, Sartore, F, Scarone, S, Sciarma, Tiziana, Siracusano, A, Strizzolo, S, Targa, G, Tasser, A, Tomasi, R, Travaglini, R, Valentini, C, Ziero, S., Barbui C., Accordini S., Nosè M., Stroup S., Purgato M., Girlanda F., Esposito E., Veronese A., Tansella M., Cipriani A., CHAT (Clozapine Haloperidol Aripiprazole Trial) Study Group […, Losavio T., Percudani M., Aldini F., Appino M.G., Artioli P., Barale F., Beneduce R., Berardi D., Bertolazzi G., Biancosino B., Bisogno A., Bivi R., Bogetto F., Boso M., Bozzani A., Bucolo P., Casale M., Cascone L., Ciammella L., Cicolini A., Cipresso G., Colombo P., Dal Santo B., De Francesco M., Di Lorenzo G., Di Munzio W., Erlicher A., Ferrannini L., Ferrato F., Ferro A., Fragomeno N., Fricchione Parise V., Frova M., Gardellin F., Garzotto N., Giambartolomei A., Giupponi G., Grassi L., Grazian N., Grecu L., Guerrini G., Laddomada F., Lazzarin E., Lintas C., Malchiodi F., Malvini L., Marchiaro L., Marsilio A., Mauri M.C., Mautone A., Menchetti M., Migliorini G., Mollica M., Moretti D., Mulè S., Nicholau S., Nosè F., Occhionero G., Pacilli A.M., Pecchioli S., Petrosemolo P., Piantato E., Piazza C., Pontarollo F., Pycha R., Quartesan R., Rillosi L., Risso F., Rizzo R., Rocca P., Roma S., Rossattini M., Rossi G., Sala A., Santilli C., Saraò G., Sarnicola A., Sartore F., Scarone S., Sciarma T., Siracusano A., Strizzolo S., Targa G., Tasser A., Tomasi R., Travaglini R., Valentini C., and Ziero S. …]
- Subjects
Adult ,Male ,medicine.medical_specialty ,antipsychotics ,aripiprazole ,clozapine ,combination strategies ,schizophrenia ,medicine.drug_class ,medicine.medical_treatment ,Drug Resistance ,Atypical antipsychotic ,Quinolones ,Piperazines ,law.invention ,Randomized controlled trial ,law ,Internal medicine ,Brief Psychiatric Rating Scale ,medicine ,Haloperidol ,Humans ,Pharmacology (medical) ,humans ,quinolones ,drug resistance ,brief psychiatric rating scale ,antipsychotic agents ,drug therapy, combination ,haloperidol ,piperazines ,adult ,female ,male ,Psychiatry ,Antipsychotic ,Settore MED/25 - Psichiatria ,Clozapine ,combination ,Randomised Controlled Trial ,Aripiprazole ,ATYPICAL ANTIPSYCHOTICS ,TREATMENT RESISTANCE ,drug therapy ,Psychiatry and Mental health ,Tolerability ,Treatment-resistant ,Schizophrenia ,Drug Therapy, Combination ,Female ,Psychology ,Antipsychotic Agents ,medicine.drug - Abstract
This multisite study was conducted to compare the efficacy and tolerability of combination treatment with clozapine plus aripiprazole versus combination treatment with clozapine plus haloperidol in patients with schizophrenia who do not have an optimal response to clozapine. Patients continued to take clozapine and were randomly assigned to receive daily augmentation with aripiprazole or haloperidol. Physicians prescribed the allocated treatments according to usual clinical care. Withdrawal from allocated treatment within 3 months was the primary outcome. Secondary outcomes included severity of symptoms on the Brief Psychiatric Rating Scale and antipsychotic subjective tolerability on the Liverpool University Neuroleptic Side Effect Rating Scale. A total of 106 patients with schizophrenia were randomly assigned to treatment. After 3 months, we found no difference in the proportion of patients who discontinued treatment between the aripiprazole and haloperidol groups (13.2% vs 15.1%, P = 0.780). The 3-month change of the Brief Psychiatric Rating Scale total score was similar in the aripiprazole and haloperidol groups (-5.9 vs -4.4 points, P = 0.523), whereas the 3-month decrease of the Liverpool University Neuroleptic Side Effect Rating Scale total score was significantly higher in the aripiprazole group than in the haloperidol group (-7.4 vs -2.0 points, P = 0.006). These results suggest that augmentation of clozapine with aripiprazole offers no benefit with regard to treatment withdrawal and overall symptoms in schizophrenia compared with augmentation with haloperidol. However, an advantage in the perception of adverse effects with aripiprazole treatment may be meaningful for patients.
- Published
- 2011
15. Kein Widerspruch: Reihenhaus und Hofhaus. Reihen-Hofhäuser in Brescia
- Author
-
Croset, PIERRE ALAIN and Bertolazzi, G.
- Published
- 2007
16. Due edifici ad appartamenti di edilizia economica popolare, Quartiere San Polo, Brescia, 1997-1999
- Author
-
Croset, PIERRE ALAIN and Bertolazzi, G.
- Published
- 2002
17. Quattordici case a schiera di edilizia economica popolare, Quartiere Badia, Brescia, 1997-1999
- Author
-
Croset, PIERRE ALAIN and Bertolazzi, G.
- Published
- 2002
18. La excepción y la norma. Dos hileras de vivienda en Brescia
- Author
-
Croset, PIERRE ALAIN and Bertolazzi, G.
- Published
- 2000
19. Alimentazione del neonato pretermine:bilancio metabolico, azotato e valutazione auxometrica, in neonati di basso peso alimentati con una formula specificamente adattata
- Author
-
Serra, G., Bertolazzi, G., Mezzano, P., Bonacci, W., Campone, F., Ravera, Giambattista, and Fantasia, A. R.
- Published
- 1992
20. Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia
- Author
-
Piantato Ennio, Percudani Mauro, Pecchioli Stefania, Pacilli Anna, Occhionero Guglielmo, Nicholau Stylianos, Nosè Flavio, Mulè Serena, Moretti Daniele, Mollica Marco, Migliorini Giuseppe, Menchetti Marco, Mautone Antonio, Mauri Massimo, Marsilio Alessandra, Marchiaro Livio, Malvini Lara, Malchiodi Francesca, Lintas Camilla, Lazzarin Ermanna, Laddomada Francesco, Guerrini Gualtiero, Grecu Lorella, Grazian Natalia, Giupponi Giancarlo, Grassi Luigi, Giambartolomei Andrea, Garzotto Nicola, Frova Maria, Gardellin Francesco, Parise Vincenzo, Fragomeno Nicoletta, Ferro Antonio, Ferrato Farida, Ferrannini Luigi, Esposito Eleonora, Erlicher Arcadio, Ducci Giuseppe, Di Munzio Walter, Di Lorenzo Giorgio, De Francesco Michele, Dal Santo Barbara, Colombo Paola, Cipriani Andrea, Cipresso Gabriele, Cicolini Alessia, Ciammella Luisa, Cascone Liliana, Casale Marcello, Bucolo Piera, Bozzani Alberto, Boso Marianna, Bogetto Filippo, Bivi Raffaella, Bisogno Alfredo, Biancosino Bruno, Bertolazzi Gerardo, Berardi Domenico, Beneduce Rossella, Barbui Corrado, Barale Francesco, Artioli Paola, Accordini Simone, Nosè Michela, Piazza Carlo, Pontarollo Francesco, Pycha Roger, Quartesan Roberto, Rillosi Luciana, Risso Francesco, Rizzo Raffella, Rocca Paola, Roma Stefania, Rossattini Matteo, Rossi Giuseppe, Rossi Giovanni, Sala Alessandra, Santilli Claudio, Saraò Giuseppe, Sarnicola Antonio, Sartore Francesca, Scarone Silvio, Sciarma Tiziana, Siracusano Alberto, Strizzolo Stefania, Tansella Michele, Targa Gino, Tasser Annamarie, Tomasi Rodolfo, Travaglini Rossana, Veronese Antonio, and Ziero Simona
- Subjects
Medicine (General) ,R5-920 - Abstract
Abstract Background One third to two thirds of people with schizophrenia have persistent psychotic symptoms despite clozapine treatment. Under real-world circumstances, the need to provide effective therapeutic interventions to patients who do not have an optimal response to clozapine has been cited as the most common reason for simultaneously prescribing a second antipsychotic drug in combination treatment strategies. In a clinical area where the pressing need of providing therapeutic answers has progressively increased the occurrence of antipsychotic polypharmacy, despite the lack of robust evidence of its efficacy, we sought to implement a pre-planned protocol where two alternative therapeutic answers are systematically provided and evaluated within the context of a pragmatic, multicentre, independent randomised study. Methods/Design The principal clinical question to be answered by the present project is the relative efficacy and tolerability of combination treatment with clozapine plus aripiprazole compared with combination treatment with clozapine plus haloperidol in patients with an incomplete response to treatment with clozapine over an appropriate period of time. This project is a prospective, multicentre, randomized, parallel-group, superiority trial that follow patients over a period of 12 months. Withdrawal from allocated treatment within 3 months is the primary outcome. Discussion The implementation of the protocol presented here shows that it is possible to create a network of community psychiatric services that accept the idea of using their everyday clinical practice to produce randomised knowledge. The employed pragmatic attitude allowed to randomly allocate more than 100 individuals, which means that this study is the largest antipsychotic combination trial conducted so far in Western countries. We expect that the current project, by generating evidence on whether it is clinically useful to combine clozapine with aripiprazole rather than with haloperidol, provides physicians with a solid evidence base to be directly applied in the routine care of patients with schizophrenia. Trial Registration Clincaltrials.gov Identifier: NCT00395915
- Published
- 2009
- Full Text
- View/download PDF
21. Constitutive psgl-1 correlates with cd30 and tcr pathways and represents a potential target for immunotherapy in anaplastic large t-cell lymphoma
- Author
-
Antonino Maiorana, Valeria Cancila, Paolo Amico, Davide Vacca, Federica Ferrante, Walter Arancio, Ines Ferrara, Pier Paolo Piccaluga, Carmela Rita Balistreri, Beatrice Belmonte, Paolo Macor, Giorgio Bertolazzi, Mohsen Navari, Sara Capolla, Alessandro Mangogna, Alessandro Gulino, Tiziana Salviato, Andrea Balduit, Gaia Morello, Belmonte, B., Cancila, V., Gulino, A., Navari, M., Arancio, W., Macor, P., Balduit, A., Capolla, S., Morello, G., Vacca, D., Ferrara, I., Bertolazzi, G., Balistreri, C. R., Amico, P., Ferrante, F., Maiorana, A., Salviato, T., Piccaluga, P. P., Mangogna, A., Belmonte B., Cancila V., Gulino A., Navari M., Arancio W., Macor P., Balduit A., Capolla S., Morello G., Vacca D., Ferrara I., Bertolazzi G., Balistreri C.R., Amico P., Ferrante F., Maiorana A., Salviato T., Piccaluga P.P., and Mangogna A.
- Subjects
0301 basic medicine ,Cancer Research ,PTCL ,CD30 ,medicine.medical_treatment ,Syk ,Lymphoproliferative disorders ,Biology ,ALCL ,ALK ,Immunotherapy ,PSGL-1 ,TCR ,Article ,03 medical and health sciences ,0302 clinical medicine ,hemic and lymphatic diseases ,medicine ,T-cell lymphoma ,RC254-282 ,integumentary system ,T-cell receptor ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Lymphoma ,Gene expression profiling ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research - Abstract
Simple Summary P-selectin glycoprotein ligand-1 (PSGL-1), coded by the SELPLG gene, is the major ligand of selectins and plays a pivotal role in tethering, rolling and extravasation of immune cells. PSGL-1 involvement in core molecular programs, such as SYK, PLCγ2, PI3Kγ or MAPK pathways, suggests additional functions beyond the modulation of cell trafficking. Recently, several studies identified a novel mechanism responsible for PSGL-1-mediated immune suppression in the tumor microenvironment and proved a novel concept of PSGL-1 as a critical checkpoint molecule for tumor immunotherapy. The immunotherapeutic approach has gained an ever-growing interest in the treatment of several hematological malignancies, and in particular, novel targets for immunotherapy are still highly sought-after in T-cell lymphomas. Based on our results obtained through gene expression profiling and immunohistochemical analysis, PSGL-1, already suggested as a potential target in multiple myeloma humoral immunotherapy, could be considered noteworthy among the candidates. Abstract Due to the high expression of P-selectin glycoprotein ligand-1 (PSGL-1) in lymphoproliferative disorders and in multiple myeloma, it has been considered as a potential target for humoral immunotherapy, as well as an immune checkpoint inhibitor in T-cells. By investigating the expression of SELPLG in 678 T- and B-cell samples by gene expression profiling (GEP), further supported by tissue microarray and immunohistochemical analysis, we identified anaplastic large T-cell lymphoma (ALCL) as constitutively expressing SELPLG at high levels. Moreover, GEP analysis in CD30+ ALCLs highlighted a positive correlation of SELPLG with TNFRSF8 (CD30-coding gene) and T-cell receptor (TCR)-signaling genes (LCK, LAT, SYK and JUN), suggesting that the common dysregulation of TCR expression in ALCLs may be bypassed by the involvement of PSGL-1 in T-cell activation and survival. Finally, we evaluated the effects elicited by in vitro treatment with two anti-PSGL-1 antibodies (KPL-1 and TB5) on the activation of the complement system and induction of apoptosis in human ALCL cell lines. In conclusion, our data demonstrated that PSGL-1 is specifically enriched in ALCLs, altering cell motility and viability due to its involvement in CD30 and TCR signaling, and it might be considered as a promising candidate for novel immunotherapeutic approaches in ALCLs.
- Published
- 2021
22. Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas
- Author
-
Vincenzo L'Imperio, Gaia Morello, Maria Carmela Vegliante, Valeria Cancila, Giorgio Bertolazzi, Saveria Mazzara, Beatrice Belmonte, Alessandro Mangogna, Piera Balzarini, Lilia Corral, Gianluca Lopez, Arianna Di Napoli, Fabio Facchetti, Fabio Pagni, Claudio Tripodo, L'Imperio, Vincenzo, Morello, Gaia, Vegliante, Maria Carmela, Cancila, Valeria, Bertolazzi, Giorgio, Mazzara, Saveria, Belmonte, Beatrice, Mangogna, Alessandro, Balzarini, Piera, Corral, Lilia, Lopez, Gianluca, Di Napoli, Arianna, Facchetti, Fabio, Pagni, Fabio, Tripodo, Claudio, L'Imperio, V, Morello, G, Vegliante, M, Cancila, V, Bertolazzi, G, Mazzara, S, Belmonte, B, Mangogna, A, Balzarini, P, Corral, L, Lopez, G, Di Napoli, A, Facchetti, F, Pagni, F, and Tripodo, C
- Subjects
Plasma Cells ,Immunology ,Germinal center ,Diffuse large B-cell lymphoma ,Digital spatial profiling ,Settore MED/08 - Anatomia Patologica ,Plasmablast ,digital spatial profiling ,germinal center ,plasmablast ,diffuse large b-cell lymphoma ,Myeloid Differentiation Factor 88 ,Tumor Microenvironment ,Humans ,Settore MED/05 - Patologia Clinica ,Immunology and Allergy ,Lymphoma, Large B-Cell, Diffuse ,Transcriptome ,CD79 Antigens ,Diffuse large B-cell lymphoma ⋅ Digital spatial profiling ⋅ Germinal center ⋅ Plasmablast - Abstract
The GC reaction results in the selection of B cells acquiring effector Ig secreting ability by progressing toward plasmablastic differentiation. This transition is associated with exclusion from the GC microenvironment. The aberrant expansion of plasmablastic elements within the GC fringes configures an atypical condition, the biological characteristics of which have not been defined yet. We investigated the in situ immunophenotypical and transcriptional characteristics of a nonclonal germinotropic expansion of plasmablastic elements (GEx) occurring in the tonsil of a young patient. Compared to neighboring GC and perifollicular regions, the GEx showed a distinctive signature featuring key regulators of plasmacytic differentiation, cytokine signaling, and cell metabolism. The GEx signature was tested in the setting of diffuse large B-cell lymphoma (DLBCL) as a prototypical model of lymphomagenesis encompassing transformation at different stages of GC and post-GC functional differentiation. The signature outlined DLBCL clusters with different immune microenvironment composition and enrichment in genetic subtypes. This report represents the first insight into the transcriptional features of a germinotropic plasmablastic burst, shedding light into the molecular hallmarks of B cells undergoing plasmablastic differentiation and aberrant expansion within the noncanonical setting of the GC microenvironment.
- Published
- 2022
23. Identification of an effective chemotherapy and DNA damage response inhibitor combination for diffuse large b cell lymphoma
- Author
-
A. Chan, A. Anbuselvan, S.S. Upadhyayula, S. Jemimah, P. Jaynes, M.M. Hoppe, J.D. Wardyn, J. Goh, G. Bertolazzi, M. Foiani, M.J. O’Connor, E.K. Chow, C. Tripodo, A.D. Jeyasekharan, Chan, A., Anbuselvan, A., Upadhyayula, S.S., Jemimah, S., Jaynes, P., Hoppe, M.M., Wardyn, J.D., Goh, J., Bertolazzi, G., Foiani, M., O’Connor, M.J., Chow, E.K., Tripodo, C., and Jeyasekharan, A.D.
- Subjects
Cancer Research ,Oncology ,DLBCL, DNA damage, chemotherapy ,Settore MED/42 - Igiene Generale E Applicata ,Settore MED/01 - Statistica Medica - Abstract
Chemotherapy forms the backbone of treatment for Diffuse Large B Cell Lymphoma (DLBCL); however
- Published
- 2022
24. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA
- Author
-
Giorgio Bertolazzi, Chiara Cipollina, Panayiotis V. Benos, Michele Tumminello, Claudia Coronnello, Bertolazzi G., Cipollina C., Benos P.V., Tumminello M., and Coronnello C.
- Subjects
0301 basic medicine ,Microbiology (medical) ,030106 microbiology ,Immunology ,lcsh:QR1-502 ,miRNA target prediction ,Inflammation ,MiRNA binding ,Endogeny ,Biology ,Microbiology ,lcsh:Microbiology ,Virus ,Transcriptome ,03 medical and health sciences ,macrophage recruitment ,microRNA ,medicine ,competing RNAs ,Gene ,microRNA regulatory network ,SARS-CoV-2 ,fungi ,RNA ,inflammatory response ,Cell biology ,030104 developmental biology ,Infectious Diseases ,medicine.symptom - Abstract
The present study focuses on the role of human miRNAs in SARS-CoV-2 infection. An extensive analysis of human miRNA binding sites on the viral genome led to the identification of miR-1207-5p as potential regulator of the viral Spike protein. It is known that exogenous RNA can compete for miRNA targets of endogenous mRNAs leading to their overexpression. Our results suggest that SARS-CoV-2 virus can act as an exogenous competing RNA, facilitating the over-expression of its endogenous targets. Transcriptomic analysis of human alveolar and bronchial epithelial cells confirmed that the CSF1 gene, a known target of miR-1207-5p, is over-expressed following SARS-CoV-2 infection. CSF1 enhances macrophage recruitment and activation and its overexpression may contribute to the acute inflammatory response observed in severe COVID-19. In summary, our results indicate that dysregulation of miR-1207-5p-target genes during SARS-CoV-2 infection may contribute to uncontrolled inflammation in most severe COVID-19 cases.
- Published
- 2020
- Full Text
- View/download PDF
25. An improvement of ComiR algorithm for microRNA target prediction by exploiting coding region sequences of mRNAs
- Author
-
Michele Tumminello, Panayiotis V. Benos, Claudia Coronnello, Giorgio Bertolazzi, Bertolazzi G., Benos P.V., Tumminello M., and Coronnello C.
- Subjects
AGO1 ,Immunoprecipitation ,Computer science ,lcsh:Computer applications to medicine. Medical informatics ,Biochemistry ,Open Reading Frames ,03 medical and health sciences ,0302 clinical medicine ,Structural Biology ,microRNA ,Melanogaster ,Animals ,Humans ,Coding region ,Gene silencing ,3'UTR ,RNA, Messenger ,Binding site ,lcsh:QH301-705.5 ,Molecular Biology ,030304 developmental biology ,0303 health sciences ,Messenger RNA ,biology ,Three prime untranslated region ,Research ,Applied Mathematics ,microRNA target prediction ,biology.organism_classification ,Computer Science Applications ,3’UTR ,MicroRNAs ,Drosophila melanogaster ,lcsh:Biology (General) ,lcsh:R858-859.7 ,DNA microarray ,Algorithm ,Algorithms ,030217 neurology & neurosurgery - Abstract
MicroRNA are small non-coding RNAs that post-transcriptionally regulate the expression levels of messenger RNAs. MicroRNA regulation activity depends on the recognition of binding sites located on mRNA molecules. ComiR is a web tool realized to predict the targets of a set of microRNAs, starting from their expression profile. ComiR was trained with the information regarding binding sites in the 3’utr region, by using a reliable dataset containing the targets of endogenously expressed microRNA in D. melanogaster S2 cells. This dataset was obtained by comparing the results from two different experimental approaches, i.e., inhibition, and immunoprecipitation of the AGO1 protein--a component of the microRNA induced silencing complex.In this work, we tested whether including coding region binding sites in ComiR algorithm improves the performance of the tool in predicting microRNA targets. We focused the analysis on the D. melanogaster species and updated the ComiR underlying database with the currently available releases of mRNA and microRNA sequences. As a result, we find that ComiR algorithm trained with the information related to the coding regions is more efficient in predicting the microRNA targets, with respect to the algorithm trained with 3’utr information. On the other hand, we show that 3’utr based predictions can be seen as complementary to the coding region based predictions, which suggests that both predictions, from 3’utr and coding regions, should be considered in comprehensive analysis.Furthermore, we observed that the lists of targets obtained by analyzing data from one experimental approach only, that is, inhibition or immunoprecipitation of AGO1, are not reliable enough to test the performance of our microRNA target prediction algorithm. Further analysis will be conducted to investigate the effectiveness of the tool with data from other species, provided that validated datasets, as obtained from the comparison of RISC proteins inhibition and immunoprecipitation experiments, will be available for the same samples. Finally, we propose to upgrade the existing ComiR web-tool by including the coding region based trained model, available together with the 3’utr based one.
- Published
- 2020
- Full Text
- View/download PDF
26. Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia
- Author
-
Paola Colombo, Luisa Ciammella, Giancarlo Giupponi, Francesco Barale, Luigi Grassi, Giorgio Di Lorenzo, Maria Frova, Michela Nosè, Gualtiero Guerrini, Liliana Cascone, Francesco Pontarollo, Rodolfo Tomasi, Alfredo Bisogno, Francesca Sartore, Guglielmo Occhionero, Claudio Santilli, Andrea Giambartolomei, Tiziana Sciarma, Marco Menchetti, Matteo Rossattini, Giuseppe Saraò, Farida Ferrato, Gabriele Cipresso, Alessandra Marsilio, Simone Accordini, Anna Maria Pacilli, Francesco Laddomada, Marianna Boso, Giuseppe Migliorini, Lara Malvini, Camilla Lintas, Antonio Ferro, Alessia Cicolini, Luciana Rillosi, Annamarie Tasser, Alberto Siracusano, Mauro Percudani, Roberto Quartesan, Nicoletta Fragomeno, Nicola Garzotto, Flavio Nosè, Corrado Barbui, Raffaella Bivi, Antonio Mautone, Rossella Beneduce, Gerardo Bertolazzi, Andrea Cipriani, Eleonora Esposito, Alberto Bozzani, Stylianos Nicholau, Barbara Dal Santo, Antonio Veronese, Gino Targa, Rossana Travaglini, Ermanna Lazzarin, Francesco Gardellin, Luigi Ferrannini, Stefania Roma, Giuseppe Rossi, Giovanni Rossi, Alessandra Sala, Bruno Biancosino, Massimo Carlo Mauri, Simona Ziero, Domenico Berardi, Roger Pycha, Walter Di Munzio, Serena Mulè, Michele De Francesco, Filippo Bogetto, Arcadio Erlicher, Carlo Piazza, Francesco Risso, Stefania Strizzolo, Marcello Casale, Vincenzo Fricchione Parise, Lorella Grecu, Silvio Scarone, Paola Artioli, Giuseppe Ducci, Raffella Rizzo, Michele Tansella, Natalia Grazian, Livio Marchiaro, Daniele Moretti, Marco Mollica, Paola Rocca, Piera Bucolo, Antonio Sarnicola, Stefania Pecchioli, Ennio Piantato, Francesca Malchiodi, Nosè M, Accordini S, Artioli P, Barale F, Barbui C, Beneduce R, Berardi D, Bertolazzi G, Biancosino B, Bisogno A, Bivi R, Bogetto F, Boso M, Bozzani A, Bucolo P, Casale M, Cascone L, Ciammella L, Cicolini A, Cipresso G, Cipriani A, Colombo P, Dal Santo B, De Francesco M, Di Lorenzo G, Di Munzio W, Ducci G, Erlicher A, Esposito E, Ferrannini L, Ferrato F, Ferro A, Fragomeno N, Parise VF, Frova M, Gardellin F, Garzotto N, Giambartolomei A, Giupponi G, Grassi L, Grazian N, Grecu L, Guerrini G, Laddomada F, Lazzarin E, Lintas C, Malchiodi F, Malvini L, Marchiaro L, Marsilio A, Mauri MC, Mautone A, Menchetti M, Migliorini G, Mollica M, Moretti D, Mulè S, Nicholau S, Nosè F, Occhionero G, Pacilli AM, Pecchioli S, Percudani M, Piantato E, Piazza C, Pontarollo F, Pycha R, Quartesan R, Rillosi L, Risso F, Rizzo R, Rocca P, Roma S, Rossattini M, Rossi G, Sala A, Santilli C, Saraò G, Sarnicola A, Sartore F, Scarone S, Sciarma T, Siracusano A, Strizzolo S, Tansella M, Targa G, Tasser A, Tomasi R, Travaglini R, Veronese A, and Ziero S.
- Subjects
REFRACTORY SCHIZOPHRENIA ,Schizophrenia ,treatment-resistance ,antipsychotics ,medicine.medical_treatment ,Aripiprazole ,piperazines ,Medicine (miscellaneous) ,Antipsychotic Agents ,Clinical Protocols ,Clozapine ,Drug Therapy, Combination ,Government Regulation ,Haloperidol ,Humans ,Italy ,Piperazines ,Prospective Studies ,Quinolones ,Research Design ,Treatment Outcome ,Drug Resistance ,Schizophrenic Psychology ,law.invention ,haloperidol ,Study Protocol ,DOUBLE-BLIND ,Randomized controlled trial ,law ,Pharmacology (medical) ,schizophrenic psychology ,humans ,antipsychotic agents, clinical protocols, clozapine, drug resistance, drug therapy, combination, government regulation, haloperidol, humans, Italy, piperazines, prospective studies, quinolones, research design, schizophrenia, schizophrenic psychology, treatment outcome ,lcsh:R5-920 ,treatment-resistant schizophrenia ,aripiprazole ,clozapine ,ANTIPSYCHOTIC DRUGS ,PRAGMATIC TRIALS ,CLINICAL TRIALS ,AUGMENTATION ,METAANALYSIS ,government regulation ,antipsychotic agents ,research design ,drug therapy ,lcsh:Medicine (General) ,medicine.drug ,medicine.medical_specialty ,Context (language use) ,medicine ,clinical protocols ,Antipsychotic ,Psychiatry ,Settore MED/25 - Psichiatria ,Polypharmacy ,combination ,drug resistance ,business.industry ,medicine.disease ,prospective studies ,Clinical trial ,schizophrenia ,treatment outcome ,quinolones ,business - Abstract
Background One third to two thirds of people with schizophrenia have persistent psychotic symptoms despite clozapine treatment. Under real-world circumstances, the need to provide effective therapeutic interventions to patients who do not have an optimal response to clozapine has been cited as the most common reason for simultaneously prescribing a second antipsychotic drug in combination treatment strategies. In a clinical area where the pressing need of providing therapeutic answers has progressively increased the occurrence of antipsychotic polypharmacy, despite the lack of robust evidence of its efficacy, we sought to implement a pre-planned protocol where two alternative therapeutic answers are systematically provided and evaluated within the context of a pragmatic, multicentre, independent randomised study. Methods/Design The principal clinical question to be answered by the present project is the relative efficacy and tolerability of combination treatment with clozapine plus aripiprazole compared with combination treatment with clozapine plus haloperidol in patients with an incomplete response to treatment with clozapine over an appropriate period of time. This project is a prospective, multicentre, randomized, parallel-group, superiority trial that follow patients over a period of 12 months. Withdrawal from allocated treatment within 3 months is the primary outcome. Discussion The implementation of the protocol presented here shows that it is possible to create a network of community psychiatric services that accept the idea of using their everyday clinical practice to produce randomised knowledge. The employed pragmatic attitude allowed to randomly allocate more than 100 individuals, which means that this study is the largest antipsychotic combination trial conducted so far in Western countries. We expect that the current project, by generating evidence on whether it is clinically useful to combine clozapine with aripiprazole rather than with haloperidol, provides physicians with a solid evidence base to be directly applied in the routine care of patients with schizophrenia. Trial Registration Clincaltrials.gov Identifier: NCT00395915
- Published
- 2009
27. Determinants of Rotavirus Vaccine Acceptance in an Area of Southern Italy with Low Vaccination Coverage: A Case-Control Study by the Health Belief Model Questionnaire.
- Author
-
Anzà D, Esposito M, Bertolazzi G, Fallucca A, Genovese C, Maniscalco G, Praticò AD, Scarpaci T, Vitale E, and Restivo V
- Abstract
Background/objectives: Rotavirus (RV) is the primary cause of gastroenteritis in children worldwide, contributing significantly to morbidity and mortality, particularly among children under five years of age. The introduction of Rotavirus vaccines (RVV) has markedly reduced RV-related childhood deaths, especially in Europe, where substantial reductions in hospitalizations and disease prevalence have been observed. Despite these advances, RVV uptake in Italy remains below the desired targets, with notable regional disparities. In Sicily, vaccination rates have fluctuated, with current coverage failing to meet national goals. Safety concerns and insufficient parental awareness are major barriers to RVV acceptance., Methods: This case-control study was conducted in Southern Italy to identify factors influencing parental acceptance of RVV. Data were collected from parents using a structured questionnaire that assessed socio-demographic factors, vaccine knowledge, and attitudes based on the Health Belief Model (HBM)., Results: Overall, 226 parents were enrolled. Higher perceived benefit of RVV was significantly associated with increased vaccine adherence (Odds Ratio = 13.65; 95% Confidence Interval = 6.88-27.09; p < 0.001)., Conclusions: These results highlight the need for targeted interventions to improve vaccine coverage and address regional and socio-economic barriers to RVV acceptance. Furthermore, tailored educational campaigns and univocal information from healthcare providers could play pivotal roles in achieving higher vaccine uptake.
- Published
- 2025
- Full Text
- View/download PDF
28. Emerging Non-Breast Implant-Associated Lymphomas: A Systematic Review.
- Author
-
Di Napoli A, Fruscione S, Mazzola S, Amodio R, Graziano G, Mannino R, Zarcone M, Bertolazzi G, Bonaccorso N, Sciortino M, De Bella DD, Savatteri A, Belluzzo M, Norrito CA, Sparacino R, Contiero P, Tagliabue G, Costantino C, and Mazzucco W
- Abstract
Background: Medical devices used for functional or esthetic purposes improve health and quality of life; however, they are not risk-free. Anaplastic large-cell lymphoma (ALCL), associated with breast implants, is a well-known and recognized distinct lymphoma entity. More recently, additional lymphomas have been reported in relation to prosthesis other than breast implants, as these allow the pericyte to develop into a clone that undergoes a maturation process, progressing toward full malignancy. Methods: We performed a systematic review with a descriptive analysis of data extracted from primary studies following PRISMA guidelines, including the search string "(IMPLANT* OR PROSTHES*) AND LYMPHOM*" in the PubMed, Scopus, Embase, and Google-Scholar databases. Data such as patient sex, age, implant site, prosthesis material, and lymphoma type were analyzed. Statistical methods, including Student's t -test and Fisher's exact test, were employed to compare lymphoma characteristics, with significance set at a p -value < 0.05. Results: From a total of 5992 studies, we obtained 43 case reports and series on a total of 52 patients diagnosed with prosthesis-associated lymphomas. The majority of implant-related lymphoma cases (85%) were of the B-cell type, mostly fibrin-associated large B-cell lymphoma (LBCL). This lymphoma type was more associated with biological (non-human-derived biological tissue), metallic, and synthetic implants (synthesized from non-organic components) ( p -value = 0.007). Patients with ALCL had equal frequencies of metal and silicone prostheses (37.5%, 3 cases each), followed by synthetic prostheses (25%, 2 cases). ALCL cases were most common at skeletal (50%) and muscular-cutaneous sites (25%), whereas B-cell lymphomas were predominantly found in cardiovascular implants (50%), followed by skeletal (27%) and muscular-cutaneous (21%) sites. Death attributed to lymphoma took place in 67% of the cases, mostly LBCL occurring in cardiovascular sites. Conclusions: Because the included studies were limited to case reports and series, a potential non-causal link might have been documented between different implant materials, implant sites and lymphoma types. This underscores the importance of further comprehensive research and monitoring of non-breast implants.
- Published
- 2024
- Full Text
- View/download PDF
29. Tetanus Vaccination in Agricultural Workers: A Retrospective Study on Seroprevalence over 10 Years.
- Author
-
Vitale E, Filetti V, Bertolazzi G, Giorgianni G, Zagorianakou N, Marino A, Esposito M, Restivo V, Matera S, Rapisarda V, and Cirrincione L
- Abstract
Background/objectives: Tetanus is a serious, non-contagious infection caused by Clostridium tetani , which remains a global health threat despite the availability of an effective vaccine. The current state of immunization for agricultural workers in Italy reveals significant disparities, reflecting a non-homogeneous distribution of vaccination coverage across regions and subgroups. The aim of the study was to investigate the prevalence of tetanus antibodies in a cohort of agricultural workers in Eastern Sicily in order to evaluate possible public health strategies for improving vaccination coverage., Methods: This observational retrospective study assessed tetanus immunization coverage in agricultural workers in Eastern Sicily during the period from 2012-2022., Results: A total of 1143 workers participated, of which 71% (n = 871) had protective tetanus antitoxin levels. Of the 835 vaccinated workers, 9% were not immune, while 19% of those who were not vaccinated or did not recall their vaccination history were immune. Significant gaps in vaccination were noted, particularly among non-European workers, with only 23% vaccinated compared to 89% of European workers. Additionally, vaccination rates were higher in those born after 1963, when vaccination became mandatory., Conclusions: The results underscore the need for targeted vaccination strategies, especially for older and migrant workers, as well as the importance of workplace immunization programs led by occupational physicians. Improving vaccination coverage among agricultural workers is essential for preventing tetanus infections in high-risk agricultural populations.
- Published
- 2024
- Full Text
- View/download PDF
30. Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior.
- Author
-
Siciliano MC, Bertolazzi G, Morello G, Tornambè S, Del Corvo M, Granai M, Sapienza MR, Leahy CI, Fennell E, Belmonte B, Arcuri F, Vannucchi M, Mancini V, Guazzo R, Boccacci R, Onyango N, Nyagol J, Santi R, Di Stefano G, Ferrara D, Bellan C, Marafioti T, Ott G, Siebert R, Quintanilla-Fend L, Fend F, Murray P, Tripodo C, Pileri S, Lazzi S, and Leoncini L
- Subjects
- Humans, Female, Male, Epstein-Barr Virus Infections complications, Epstein-Barr Virus Infections immunology, Gene Expression Profiling, Herpesvirus 4, Human, Adult, Transcriptome, Middle Aged, Gene Expression Regulation, Neoplastic, Child, Adolescent, Prognosis, Tumor Microenvironment immunology, Burkitt Lymphoma immunology, Burkitt Lymphoma pathology, Burkitt Lymphoma genetics
- Abstract
Abstract: Burkitt lymphoma (BL) is characterized by a tumor microenvironment (TME) in which macrophages represent the main component, determining a distinct histological appearance known as "starry sky" pattern. However, in some instances, BL may exhibit a granulomatous reaction that has been previously linked to favorable prognosis and spontaneous regression. The aim of our study was to deeply characterize the immune landscape of 7 cases of Epstein-Barr virus-positive (EBV+) BL with granulomatous reaction compared with 8 cases of EBV+ BL and 8 EBV-negative (EBV-) BL, both with typical starry sky pattern, by Gene expression profiling performed on the NanoString nCounter platform. Subsequently, the data were validated using multiplex and combined immunostaining. Based on unsupervised clustering of differentially expressed genes, BL samples formed 3 distinct clusters differentially enriched in BL with a diffuse granulomatous reaction (cluster 1), EBV+ BL with typical starry sky pattern (cluster 2), EBV- BL with typical "starry sky" (cluster 3). We observed variations in the immune response signature among BL with granulomatous reaction and BL with typical "starry sky," both EBV+ and EBV-. The TME signature in BL with diffuse granulomatous reaction showed a proinflammatory response, whereas BLs with "starry sky" were characterized by upregulation of M2 polarization and protumor response. Moreover, the analysis of additional signatures revealed an upregulation of the dark zone signature and epigenetic signature in BL with a typical starry sky. Tumor-associated macrophages and epigenetic regulators may be promising targets for additional therapies for BL lymphoma, opening novel immunotherapeutic strategies., (© 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
31. PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis.
- Author
-
Belmonte B, Di Lorenzo G, Mangogna A, Bortot B, Bertolazzi G, Sammataro S, Merighi S, Martorana A, Zito G, Romano F, Giorgiutti A, Bottin C, Zanconati F, Romano A, Ricci G, and Biffi S
- Subjects
- Female, Humans, Adult, Biomarkers metabolism, Immunohistochemistry, Endometrium metabolism, Endometrium pathology, Endometrium surgery, Endometriosis metabolism, Endometriosis surgery, Endometriosis genetics, Endometriosis diagnosis, Endometriosis pathology, Poly (ADP-Ribose) Polymerase-1 metabolism, Poly (ADP-Ribose) Polymerase-1 genetics, Folate Receptor 1 genetics, Folate Receptor 1 metabolism, Epithelial Cell Adhesion Molecule genetics, Epithelial Cell Adhesion Molecule metabolism
- Abstract
Background: Endometriosis is a gynecological disease characterized by the presence of endometrial tissue in abnormal locations, leading to severe symptoms, inflammation, pain, organ dysfunction, and infertility. Surgical removal of endometriosis lesions is crucial for improving pain and fertility outcomes, with the goal of complete lesion removal. This study aimed to analyze the location and expression patterns of poly (ADP-ribose) polymerase 1 (PARP-1), epithelial cell adhesion molecule (EpCAM), and folate receptor alpha (FRα) in endometriosis lesions and evaluate their potential for targeted imaging., Methods: Gene expression analysis was performed using the Turku endometriosis database (EndometDB). By immunohistochemistry, we investigated the presence and distribution of PARP-1, EpCAM, and FRα in endometriosis foci and adjacent tissue. We also applied an ad hoc platform for the analysis of images to perform a quantitative immunolocalization analysis. Double immunofluorescence analysis was carried out for PARP-1 and EpCAM, as well as for PARP-1 and FRα, to explore the expression of these combined markers within endometriosis foci and their potential simultaneous utilization in surgical treatment., Results: Gene expression analysis revealed that PARP-1, EpCAM, and FOLR1 (FRα gene) are more highly expressed in endometriotic lesions than in the peritoneum, which served as the control tissue. The results of the immunohistochemical study revealed a significant increase in the expression levels of all three biomarkers inside the endometriosis foci compared to the adjacent tissues. Additionally, the double immunofluorescence analysis consistently demonstrated the presence of PARP-1 in the nucleus and the expression of EpCAM and FRα in the cell membrane and cytoplasm., Conclusion: Overall, these three markers demonstrate significant potential for effective imaging of endometriosis. In particular, the results emphasize the importance of PARP-1 expression as a possible indicator for distinguishing endometriotic lesions from adjacent tissue. PARP-1, as a potential biomarker for endometriosis, offers promising avenues for further investigation in terms of both pathophysiology and diagnostic-therapeutic approaches., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
32. ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization.
- Author
-
Pennisi G, Maurotti S, Ciociola E, Jamialahmadi O, Bertolazzi G, Mirarchi A, Bergh PO, Scionti F, Mancina RM, Spagnuolo R, Tripodo C, Boren J, Petta S, and Romeo S
- Subjects
- Humans, Angiopoietins metabolism, Angiopoietins genetics, Hep G2 Cells, Lipid Metabolism, Transfection, Angiopoietin-Like Protein 3 genetics, Angiopoietin-Like Protein 3 metabolism, Angiopoietin-like Proteins metabolism, Angiopoietin-like Proteins genetics, Down-Regulation, Energy Metabolism genetics, Hepatocytes metabolism, RNA Interference, Triglycerides metabolism
- Abstract
Background: ANGPTL3 (angiopoietin-like protein 3) is a circulating protein with a key role in maintaining lipoprotein homeostasis. A monoclonal antibody against ANGPTL3 is an approved and well-tolerated treatment to reduce lipoproteins in familial hypercholesterolemia homozygotes. However, the reduction of hepatic ANGPTL3 synthesis using an antisense oligonucleotide unexpectedly resulted in a dose-dependent increase in liver lipid content and circulating transaminases, resulting in the termination of the clinical trial. Meanwhile, the use of silencing RNAs remains an area of active investigation. Our study sought to investigate whether intracellular downregulation of ANGPTL3 may lead to a primary increase in neutral lipids within the hepatocyte., Methods: We downregulated ANGPTL3 by silencing RNA in primary human hepatocytes 3-dimensional spheroids, HepG2/LX-2 3-dimensional spheroids, and in HepG2, Hep3B2, and Huh7 cultured in 2 dimensions., Results: ANGPTL3 downregulation increased neutral lipids in all models investigated. Interestingly, ANGPTL3 induced lower intracellular deiodinase type 1 protein levels resulting in a reduction in beta-oxidation and causing an increase in triglycerides stored in lipid droplets., Conclusions: In conclusion, intracellular ANGPTL3 downregulation by silencing RNA led to an increase in triglycerides content due to a reduction in energy substrate utilization resembling a primary intracellular hepatocyte hypothyroidism., Competing Interests: Disclosures S. Romeo has served as consultant and received fees for lecture by Ultragenyx, AstraZeneca, Novartis, AMGEN, Sanofi-Aventis, Ribocure AB, and Foresite Labs.
- Published
- 2024
- Full Text
- View/download PDF
33. Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphoma.
- Author
-
Cancila V, Morello G, Bertolazzi G, Chan AS, Bastianello G, Paysan D, Jaynes PW, Schiavoni G, Mattei F, Piconese S, Revuelta MV, Noto F, De Ninno A, Cammarata I, Pagni F, Venkatachalapathy S, Sangaletti S, Di Napoli A, Vacca D, Lonardi S, Lorenzi L, Ferreri AJM, Belmonte B, Varano G, Colombo MP, Bicciato S, Inghirami G, Cerchietti L, Ponzoni M, Zappasodi R, Facchetti F, Foiani M, Casola S, Jeyasekharan AD, and Tripodo C
- Abstract
The germinal center (GC) dark zone (DZ) and light zone (LZ) regions spatially separate expansion and diversification from selection of antigen-specific B-cells to ensure antibody affinity maturation and B cell memory. The DZ and LZ differ significantly in their immune composition despite the lack of a physical barrier, yet the determinants of this polarization are poorly understood. This study provides novel insights into signals controlling asymmetric T-cell distribution between DZ and LZ regions. We identify spatially-resolved DNA damage response and chromatin compaction molecular features that underlie DZ T-cell exclusion. The DZ spatial transcriptional signature linked to T-cell immune evasion clustered aggressive Diffuse Large B-cell Lymphomas (DLBCL) for differential T cell infiltration. We reveal the dependence of the DZ transcriptional core signature on the ATR kinase and dissect its role in restraining inflammatory responses contributing to establishing an immune-repulsive imprint in DLBCL. These insights may guide ATR-focused treatment strategies bolstering immunotherapy in tumors marked by DZ transcriptional and chromatin-associated features., Competing Interests: CONFLICT OF INTERESTS ADJ has received consultancy fees from DKSH/Beigene, Roche, Gilead, Turbine Ltd, AstraZeneca, Antengene, Janssen, MSD and IQVIA; and research funding from Janssen and AstraZeneca.
- Published
- 2024
- Full Text
- View/download PDF
34. Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma.
- Author
-
Liu M, Bertolazzi G, Sridhar S, Lee RX, Jaynes P, Mulder K, Syn N, Hoppe MM, Fan S, Peng Y, Thng J, Chua R, Jayalakshmi, Batumalai Y, De Mel S, Poon L, Chan EHL, Lee J, Hue SS, Chang ST, Chuang SS, Chandy KG, Ye X, Pan-Hammarström Q, Ginhoux F, Chee YL, Ng SB, Tripodo C, and Jeyasekharan AD
- Subjects
- Humans, Prognosis, Gene Expression Profiling, Transcriptome, Germinal Center pathology, Tumor Microenvironment genetics, Lymphoma, Large B-Cell, Diffuse pathology
- Abstract
Macrophages are abundant immune cells in the microenvironment of diffuse large B-cell lymphoma (DLBCL). Macrophage estimation by immunohistochemistry shows varying prognostic significance across studies in DLBCL, and does not provide a comprehensive analysis of macrophage subtypes. Here, using digital spatial profiling with whole transcriptome analysis of CD68+ cells, we characterize macrophages in distinct spatial niches of reactive lymphoid tissues (RLTs) and DLBCL. We reveal transcriptomic differences between macrophages within RLTs (light zone /dark zone, germinal center/ interfollicular), and between disease states (RLTs/ DLBCL), which we then use to generate six spatially-derived macrophage signatures (MacroSigs). We proceed to interrogate these MacroSigs in macrophage and DLBCL single-cell RNA-sequencing datasets, and in gene-expression data from multiple DLBCL cohorts. We show that specific MacroSigs are associated with cell-of-origin subtypes and overall survival in DLBCL. This study provides a spatially-resolved whole-transcriptome atlas of macrophages in reactive and malignant lymphoid tissues, showing biological and clinical significance., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
35. Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle.
- Author
-
Tripodo C, Bertolazzi G, Cancila V, Morello G, and Iannitto E
- Subjects
- Female, Humans, Germinal Center, Ovarian Follicle, Nonoxynol, Tumor Microenvironment genetics, Lymphoid Tissue, Lymphoma, Large B-Cell, Diffuse genetics
- Abstract
We have established a pseudotemporal ordering for the transcriptional signatures of distinct microregions within reactive lymphoid tissues, namely germinal center dark zones (DZ), germinal center light zones (LZ), and peri-follicular areas (Peri). By utilizing this pseudotime trajectory derived from the functional microenvironments of DZ, LZ, and Peri, we have ordered the transcriptomes of Diffuse Large B-cell Lymphoma cases. The apex of the resulting pseudotemporal trajectory, which is characterized by enrichment of molecular programs fronted by TNFR signaling and inhibitory immune checkpoint overexpression, intercepts a discrete peri-follicular biology. This observation is associated with DLBCL cases that are enriched in the Unclassified/type-3 COO category, raising questions about the potential extra-GC microenvironment imprint of this peculiar group of cases. This report offers a thought-provoking perspective on the relationship between transcriptional profiling of functional lymphoid tissue microenvironments and the evolving concept of the cell of origin in Diffuse Large B-cell Lymphomas., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Tripodo, Bertolazzi, Cancila, Morello and Iannitto.)
- Published
- 2023
- Full Text
- View/download PDF
36. No Clear Clustering Dysbiosis from Salivary Microbiota Analysis by Long Sequencing Reads in Patients Affected by Oral Squamous Cell Carcinoma: A Single Center Study.
- Author
-
Mauceri R, Coppini M, Vacca D, Bertolazzi G, Cancila V, Tripodo C, and Campisi G
- Abstract
Background: Advancements in DNA sequencing technology have facilitated the assessment of the connection between the oral microbiome and various diseases. The aim of the present study was to investigate the salivary microbiota composition employing for the first time in the literature the Oxford Nanopore Technology in patients affected by oral squamous cell carcinoma (OSCC)., Methods: Unstimulated saliva samples of 31 patients were collected (24 OSCC patients and 7 controls). DNA was extracted using the QIAamp DNA Blood Kit and metagenomic long sequencing reads were performed using the MinION device., Results: In the OSCC group, 13 were males and 11 were females, with a mean age of 65.5 ± 13.9 years; in the control group, 5 were males and 2 were females, with a mean age of 51.4 ± 19.2 years. The border of the tongue was the most affected OSCC site. The microorganisms predominantly detected in OSCC patients were Prevotella , Chlamydia , Tissierellia , Calothrix , Leotiomycetes , Firmicutes and Zetaproteobacteria ., Conclusions: This study confirmed the predominance of periodontopathic bacteria in the salivary microbiome in the OSCC group. If a direct correlation between oral dysbiosis and OSCC onset was proven, it could lead to new prevention strategies and early diagnostic tools., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2023
- Full Text
- View/download PDF
37. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.
- Author
-
Pipitone RM, Malvestiti F, Pennisi G, Jamialahmadi O, Dongiovanni P, Bertolazzi G, Pihlajamäki J, Yki-Järvinen H, Vespasiani-Gentilucci U, Tavaglione F, Maurotti S, Bianco C, Di Maria G, Enea M, Fracanzani AL, Kärjä V, Lupo G, Männistö V, Meroni M, Piciotti R, Qadri S, Zito R, Craxì A, Di Marco V, Cammà C, Tripodo C, Valenti L, Romeo S, Petta S, and Grimaudo S
- Subjects
- Humans, Liver pathology, Inflammation pathology, Apoptosis, Liver Cirrhosis complications, Non-alcoholic Fatty Liver Disease complications, Carcinoma, Hepatocellular pathology, Liver Neoplasms pathology
- Abstract
Background and Aims: Programmed cell death 1/programmed cell death-ligand 1 (PD-1/PDL-1) axis has been reported to modulate liver inflammation and progression to hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease (NAFLD). Here, we examined whether the PDCD1 variation is associated with NAFLD severity in individuals with liver biopsy., Methods: We examined the impact of PDCD1 gene variants on HCC, as robust severe liver disease phenotype in UK Biobank participants. The strongest genetic association with the rs13023138 G>C variation was subsequently tested for association with liver damage in 2889 individuals who underwent liver biopsy for suspected nonalcoholic steatohepatitis (NASH). Hepatic transcriptome was examined by RNA-Seq in a subset of NAFLD individuals (n = 121). Transcriptomic and deconvolution analyses were performed to identify biological pathways modulated by the risk allele., Results: The rs13023138 C>G showed the most robust association with HCC in UK Biobank (p = 5.28E-4, OR = 1.32, 95% CI [1.1, 1.5]). In the liver biopsy cohort, rs13023138 G allele was independently associated with severe steatosis (OR 1.17, 95% CI 1.02-1.34; p = .01), NASH (OR 1.22, 95% CI 1.09-1.37; p < .001) and advanced fibrosis (OR 1.26, 95% CI 1.06-1.50; p = .007). At deconvolution analysis, rs13023138 G>C allele was linked to higher hepatic representation of M1 macrophages, paralleled by upregulation of pathways related to inflammation and higher expression of CXCR6., Conclusions: The PDCD1 rs13023138 G allele was associated with HCC development in the general population and with liver disease severity in patients at high risk of NASH., (© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
38. Salivary Microbiota Composition in Patients with Oral Squamous Cell Carcinoma: A Systematic Review.
- Author
-
Mauceri R, Coppini M, Vacca D, Bertolazzi G, Panzarella V, Di Fede O, Tripodo C, and Campisi G
- Abstract
Background: Oral squamous cell carcinoma (OSCC) is one of the most prevalent cancers worldwide. Despite recent advances in diagnosis and treatment, in recent years, an increase in the incidence of OSCC has been registered, and the mortality rate is still high. This systematic review aims to identify a potential association between the composition of salivary microbiota and OSCC., Materials and Methods: The protocol for this study was designed following the PRISMA guidelines. Records were identified using different search engines (e.g., Medline/PubMed). Observational studies, in human subjects with histological diagnosis of OSCC, concerning the analysis of salivary microbiota, were selected., Results: Eleven papers were included. The salivary microbiomes of 1335 patients were analysed (n.687 OSCC and n.648 controls). Due to the great heterogeneity of the studies, it was not possible to profile a specific microbiota associated with OSCC. However, periodontal pathogens were the most common bacteria detected in patients with OSCC (i.e., Fusobacterium , Prevotella )., Conclusions: Although there are evident alterations in the salivary microbiota composition in OSCC patients, it is still a challenge to identify a specific microbiota pattern in OSCC patients. If the associations between specific salivary microorganisms and OSCC are confirmed, microbiome analysis could be a useful tool for the screening and follow-up of patients affected by OSCC.
- Published
- 2022
- Full Text
- View/download PDF
39. Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas.
- Author
-
L'Imperio V, Morello G, Vegliante MC, Cancila V, Bertolazzi G, Mazzara S, Belmonte B, Mangogna A, Balzarini P, Corral L, Lopez G, Di Napoli A, Facchetti F, Pagni F, and Tripodo C
- Subjects
- CD79 Antigens genetics, CD79 Antigens metabolism, Germinal Center metabolism, Humans, Plasma Cells metabolism, Transcriptome, Tumor Microenvironment genetics, Lymphoma, Large B-Cell, Diffuse genetics, Lymphoma, Large B-Cell, Diffuse metabolism, Lymphoma, Large B-Cell, Diffuse pathology, Myeloid Differentiation Factor 88 genetics, Myeloid Differentiation Factor 88 metabolism
- Abstract
The GC reaction results in the selection of B cells acquiring effector Ig secreting ability by progressing toward plasmablastic differentiation. This transition is associated with exclusion from the GC microenvironment. The aberrant expansion of plasmablastic elements within the GC fringes configures an atypical condition, the biological characteristics of which have not been defined yet. We investigated the in situ immunophenotypical and transcriptional characteristics of a nonclonal germinotropic expansion of plasmablastic elements (GEx) occurring in the tonsil of a young patient. Compared to neighboring GC and perifollicular regions, the GEx showed a distinctive signature featuring key regulators of plasmacytic differentiation, cytokine signaling, and cell metabolism. The GEx signature was tested in the setting of diffuse large B-cell lymphoma (DLBCL) as a prototypical model of lymphomagenesis encompassing transformation at different stages of GC and post-GC functional differentiation. The signature outlined DLBCL clusters with different immune microenvironment composition and enrichment in genetic subtypes. This report represents the first insight into the transcriptional features of a germinotropic plasmablastic burst, shedding light into the molecular hallmarks of B cells undergoing plasmablastic differentiation and aberrant expansion within the noncanonical setting of the GC microenvironment., (© 2022 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.)
- Published
- 2022
- Full Text
- View/download PDF
40. A multivariate statistical test for differential expression analysis.
- Author
-
Tumminello M, Bertolazzi G, Sottile G, Sciaraffa N, Arancio W, and Coronnello C
- Subjects
- Female, Gene Expression Profiling methods, Gene Ontology, Humans, Models, Statistical, Breast Neoplasms genetics, Kidney Neoplasms genetics
- Abstract
Statistical tests of differential expression usually suffer from two problems. Firstly, their statistical power is often limited when applied to small and skewed data sets. Secondly, gene expression data are usually discretized by applying arbitrary criteria to limit the number of false positives. In this work, a new statistical test obtained from a convolution of multivariate hypergeometric distributions, the Hy-test, is proposed to address these issues. Hy-test has been carried out on transcriptomic data from breast and kidney cancer tissues, and it has been compared with other differential expression analysis methods. Hy-test allows implicit discretization of the expression profiles and is more selective in retrieving both differential expressed genes and terms of Gene Ontology. Hy-test can be adopted together with other tests to retrieve information that would remain hidden otherwise, e.g., terms of (1) cell cycle deregulation for breast cancer and (2) "programmed cell death" for kidney cancer., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
41. RNA Sequencing of Primary Cutaneous and Breast-Implant Associated Anaplastic Large Cell Lymphomas Reveals Infrequent Fusion Transcripts and Upregulation of PI3K/AKT Signaling via Neurotrophin Pathway Genes.
- Author
-
Di Napoli A, Vacca D, Bertolazzi G, Lopez G, Piane M, Germani A, Rogges E, Pepe G, Santanelli Di Pompeo F, Salgarello M, Jobanputra V, Hsiao S, Wrzeszczynski KO, Berti E, and Bhagat G
- Abstract
Cutaneous and breast implant-associated anaplastic large-cell lymphomas (cALCLs and BI-ALCLs) are two localized forms of peripheral T-cell lymphomas (PTCLs) that are recognized as distinct entities within the family of ALCL. JAK-STAT signaling is a common feature of all ALCL subtypes, whereas DUSP22/IRF4, TP63 and TYK gene rearrangements have been reported in a proportion of ALK-negative sALCLs and cALCLs. Both cALCLs and BI-ALCLs differ in their gene expression profiles compared to PTCLs; however, a direct comparison of the genomic alterations and transcriptomes of these two entities is lacking. By performing RNA sequencing of 1385 genes (TruSight RNA Pan-Cancer, Illumina) in 12 cALCLs, 10 BI-ALCLs and two anaplastic lymphoma kinase (ALK)-positive sALCLs, we identified the previously reported TYK2-NPM1 fusion in 1 cALCL (1/12, 8%), and four new intrachromosomal gene fusions in 2 BI-ALCLs (2/10, 20%) involving genes on chromosome 1 (EPS15-GNG12 and ARNT-GOLPH3L) and on chromosome 17 (MYO18A-GIT1 and NF1-GOSR1). One of the two BI-ALCL samples showed a complex karyotype, raising the possibility that genomic instability may be responsible for intra-chromosomal fusions in BI-ALCL. Moreover, transcriptional analysis revealed similar upregulation of the PI3K/Akt pathway, associated with enrichment in the expression of neurotrophin signaling genes, which was more conspicuous in BI-ALCL, as well as differences, i.e., over-expression of genes involved in the RNA polymerase II transcription program in BI-ALCL and of the RNA splicing/processing program in cALCL.
- Published
- 2021
- Full Text
- View/download PDF
42. Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell Lymphoma.
- Author
-
Belmonte B, Cancila V, Gulino A, Navari M, Arancio W, Macor P, Balduit A, Capolla S, Morello G, Vacca D, Ferrara I, Bertolazzi G, Balistreri CR, Amico P, Ferrante F, Maiorana A, Salviato T, Piccaluga PP, and Mangogna A
- Abstract
Due to the high expression of P-selectin glycoprotein ligand-1 (PSGL-1) in lymphoproliferative disorders and in multiple myeloma, it has been considered as a potential target for humoral immunotherapy, as well as an immune checkpoint inhibitor in T-cells. By investigating the expression of SELPLG in 678 T- and B-cell samples by gene expression profiling (GEP), further supported by tissue microarray and immunohistochemical analysis, we identified anaplastic large T-cell lymphoma (ALCL) as constitutively expressing SELPLG at high levels. Moreover, GEP analysis in CD30+ ALCLs highlighted a positive correlation of SELPLG with TNFRSF8 (CD30-coding gene) and T-cell receptor (TCR)-signaling genes ( LCK, LAT, SYK and JUN ), suggesting that the common dysregulation of TCR expression in ALCLs may be bypassed by the involvement of PSGL-1 in T-cell activation and survival. Finally, we evaluated the effects elicited by in vitro treatment with two anti-PSGL-1 antibodies (KPL-1 and TB5) on the activation of the complement system and induction of apoptosis in human ALCL cell lines. In conclusion, our data demonstrated that PSGL-1 is specifically enriched in ALCLs, altering cell motility and viability due to its involvement in CD30 and TCR signaling, and it might be considered as a promising candidate for novel immunotherapeutic approaches in ALCLs.
- Published
- 2021
- Full Text
- View/download PDF
43. RIP-Chip analysis supports different roles for AGO2 and GW182 proteins in recruiting and processing microRNA targets.
- Author
-
Perconti G, Rubino P, Contino F, Bivona S, Bertolazzi G, Tumminello M, Feo S, Giallongo A, and Coronnello C
- Subjects
- Argonaute Proteins genetics, Autoantigens genetics, Binding Sites, Gene Expression Profiling, Gene Expression Regulation, Humans, MCF-7 Cells, MicroRNAs genetics, Open Reading Frames genetics, RNA, Messenger genetics, RNA, Messenger metabolism, RNA-Binding Proteins genetics, Support Vector Machine, Argonaute Proteins metabolism, Autoantigens metabolism, Chromatin Immunoprecipitation methods, MicroRNAs metabolism, RNA-Binding Proteins metabolism
- Abstract
Background: MicroRNAs (miRNAs) are small non-coding RNA molecules mediating the translational repression and degradation of target mRNAs in the cell. Mature miRNAs are used as a template by the RNA-induced silencing complex (RISC) to recognize the complementary mRNAs to be regulated. To discern further RISC functions, we analyzed the activities of two RISC proteins, AGO2 and GW182, in the MCF-7 human breast cancer cell line., Methods: We performed three RIP-Chip experiments using either anti-AGO2 or anti-GW182 antibodies and compiled a data set made up of the miRNA and mRNA expression profiles of three samples for each experiment. Specifically, we analyzed the input sample, the immunoprecipitated fraction and the unbound sample resulting from the RIP experiment. We used the expression profile of the input sample to compute several variables, using formulae capable of integrating the information on miRNA binding sites, both in the 3'UTR and coding regions, with miRNA and mRNA expression level profiles. We compared immunoprecipitated vs unbound samples to determine the enriched or underrepresented genes in the immunoprecipitated fractions, independently for AGO2 and GW182 related samples., Results: For each of the two proteins, we trained and tested several support vector machine algorithms capable of distinguishing the enriched from the underrepresented genes that were experimentally detected. The most efficient algorithm for distinguishing the enriched genes in AGO2 immunoprecipitated samples was trained by using variables involving the number of binding sites in both the 3'UTR and coding region, integrated with the miRNA expression profile, as expected for miRNA targets. On the other hand, we found that the best variable for distinguishing the enriched genes in the GW182 immunoprecipitated samples was the length of the coding region., Conclusions: Due to the major role of GW182 in GW/P-bodies, our data suggests that the AGO2-GW182 RISC recruits genes based on miRNA binding sites in the 3'UTR and coding region, but only the longer mRNAs probably remain sequestered in GW/P-bodies, functioning as a repository for translationally silenced RNAs.
- Published
- 2019
- Full Text
- View/download PDF
44. Combined diagnostic imaging of acquired valvular disease.
- Author
-
Schicchi F, Piva R, Costantini C, Bertolazzi G, Pangrazi A, Gabrielli G, Gili A, Lanza R, Falappa P, and Marano P
- Subjects
- Aged, Humans, Diagnostic Imaging, Heart Valve Diseases diagnosis
- Published
- 1993
45. Combined diagnostic imaging of congenital heart disease.
- Author
-
Piva R, Schicchi F, Pangrazi A, Bettuzzi MG, Bertolazzi G, Gabrielli G, Lanza R, Falappa P, and Marano P
- Subjects
- Adolescent, Child, Child, Preschool, Heart Defects, Congenital epidemiology, Humans, Incidence, Infant, Infant, Newborn, Italy epidemiology, Diagnostic Imaging, Heart Defects, Congenital diagnosis
- Published
- 1993
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.